SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,206,018 | +1.1% | 9,949 | -4.4% | 0.00% | 0.0% |
| Q2 2023 | $1,192,382 | -8.0% | 10,412 | +10.8% | 0.00% | 0.0% |
| Q1 2023 | $1,295,602 | -36.2% | 9,400 | -40.0% | 0.00% | -50.0% |
| Q4 2022 | $2,030,130 | +57.9% | 15,667 | +34.7% | 0.00% | +33.3% |
| Q3 2022 | $1,286,000 | +35.7% | 11,631 | -8.0% | 0.00% | +50.0% |
| Q2 2022 | $948,000 | +23.4% | 12,643 | +28.5% | 0.00% | +100.0% |
| Q1 2022 | $768,000 | -17.9% | 9,837 | -5.3% | 0.00% | -50.0% |
| Q4 2021 | $936,000 | -55.1% | 10,392 | -53.9% | 0.00% | -50.0% |
| Q3 2021 | $2,083,000 | -14.1% | 22,524 | -27.8% | 0.00% | -20.0% |
| Q2 2021 | $2,425,000 | +6.3% | 31,190 | +1.9% | 0.01% | 0.0% |
| Q1 2021 | $2,282,000 | +8.7% | 30,618 | +148.6% | 0.01% | 0.0% |
| Q4 2020 | $2,100,000 | +24.6% | 12,317 | +2.6% | 0.01% | 0.0% |
| Q3 2020 | $1,686,000 | -5.6% | 12,007 | +7.8% | 0.01% | -16.7% |
| Q2 2020 | $1,786,000 | +53.0% | 11,137 | -6.6% | 0.01% | +20.0% |
| Q1 2020 | $1,167,000 | -33.7% | 11,929 | -12.6% | 0.01% | -16.7% |
| Q4 2019 | $1,761,000 | +51.7% | 13,649 | -11.5% | 0.01% | +50.0% |
| Q3 2019 | $1,161,000 | -51.5% | 15,419 | -2.2% | 0.00% | -55.6% |
| Q2 2019 | $2,395,000 | +17.1% | 15,765 | -8.1% | 0.01% | +12.5% |
| Q1 2019 | $2,045,000 | +49.8% | 17,154 | +37.1% | 0.01% | +14.3% |
| Q4 2018 | $1,365,000 | -27.5% | 12,512 | +7.3% | 0.01% | -22.2% |
| Q3 2018 | $1,883,000 | +16.3% | 11,660 | -4.8% | 0.01% | +12.5% |
| Q2 2018 | $1,619,000 | +80.3% | 12,252 | +1.1% | 0.01% | +60.0% |
| Q1 2018 | $898,000 | -13.4% | 12,121 | -35.0% | 0.01% | -16.7% |
| Q4 2017 | $1,037,000 | -18.5% | 18,639 | -63.0% | 0.01% | -25.0% |
| Q3 2017 | $1,272,000 | +80.7% | 50,396 | +141.5% | 0.01% | +60.0% |
| Q2 2017 | $704,000 | +111.4% | 20,871 | +85.8% | 0.01% | +66.7% |
| Q1 2017 | $333,000 | +50.7% | 11,236 | +39.4% | 0.00% | +50.0% |
| Q4 2016 | $221,000 | -67.5% | 8,063 | -67.0% | 0.00% | -66.7% |
| Q3 2016 | $680,000 | – | 24,461 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |